Chuan‐Hao Lin

806 total citations
15 papers, 476 citations indexed

About

Chuan‐Hao Lin is a scholar working on Surgery, Epidemiology and Hepatology. According to data from OpenAlex, Chuan‐Hao Lin has authored 15 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Chuan‐Hao Lin's work include Liver Disease Diagnosis and Treatment (6 papers), Hepatitis B Virus Studies (5 papers) and Hepatitis C virus research (5 papers). Chuan‐Hao Lin is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Hepatitis B Virus Studies (5 papers) and Hepatitis C virus research (5 papers). Chuan‐Hao Lin collaborates with scholars based in United States, Australia and United Kingdom. Chuan‐Hao Lin's co-authors include Ronald Thomas, Vasundhara Tolia, John Peters, Philip Rosenthal, Regino P. González‐Peralta, Ahmed Dahshan, Kathryn Kersey, Benedetta Massetto, Maureen M. Jonas and Diana M. Brainard and has published in prestigious journals such as Hepatology, The American Journal of Gastroenterology and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.

In The Last Decade

Chuan‐Hao Lin

15 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuan‐Hao Lin United States 10 270 261 111 83 68 15 476
Manik Sharma Qatar 11 146 0.5× 160 0.6× 290 2.6× 159 1.9× 66 1.0× 28 509
Praveer Rai India 12 146 0.5× 128 0.5× 278 2.5× 103 1.2× 130 1.9× 81 436
Juan Cristóbal Gana Chile 12 409 1.5× 396 1.5× 351 3.2× 56 0.7× 79 1.2× 58 686
Amine Benmassaoud Canada 13 230 0.9× 284 1.1× 122 1.1× 26 0.3× 23 0.3× 38 433
Qais Contractor India 12 119 0.4× 154 0.6× 218 2.0× 34 0.4× 53 0.8× 47 405
C. Barbera Italy 13 227 0.8× 276 1.1× 78 0.7× 19 0.2× 39 0.6× 30 502
Rekha Cheruvattath United States 7 234 0.9× 201 0.8× 166 1.5× 22 0.3× 49 0.7× 8 370
Andrew Kirk United Kingdom 5 200 0.7× 195 0.7× 126 1.1× 21 0.3× 37 0.5× 6 342
R. Valderrama Spain 9 175 0.6× 188 0.7× 233 2.1× 84 1.0× 30 0.4× 15 372
Neelam Mohan India 13 254 0.9× 210 0.8× 219 2.0× 21 0.3× 20 0.3× 48 481

Countries citing papers authored by Chuan‐Hao Lin

Since Specialization
Citations

This map shows the geographic impact of Chuan‐Hao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuan‐Hao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuan‐Hao Lin more than expected).

Fields of papers citing papers by Chuan‐Hao Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuan‐Hao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuan‐Hao Lin. The network helps show where Chuan‐Hao Lin may publish in the future.

Co-authorship network of co-authors of Chuan‐Hao Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chuan‐Hao Lin. A scholar is included among the top collaborators of Chuan‐Hao Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuan‐Hao Lin. Chuan‐Hao Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
González‐Peralta, Regino P., Jessica Wen, Winita Hardikar, et al.. (2025). Long-term efficacy and safety of sofosbuvir-based direct-acting antiviral regimens in paediatric patients with hepatitis C virus infection: an international registry study. The Lancet Child & Adolescent Health. 9(4). 248–254. 1 indexed citations
2.
Leung, Daniel H., James E. Squires, Ravi Jhaveri, et al.. (2020). Hepatitis C in 2020. Journal of Pediatric Gastroenterology and Nutrition. 71(3). 407–417. 16 indexed citations
3.
Dong, Xi, Yuri Genyk, Dan W. Thomas, et al.. (2019). Severe Late-Onset Acute Cellular Rejection in a Pediatric Patient With Isolated Small Intestinal Transplant Rescued With Aggressive Immunosuppressive Approach: A Case Report. Transplantation Proceedings. 51(9). 3181–3185. 3 indexed citations
4.
Black, Dennis D., Cara L. Mack, Nanda Kerkar, et al.. (2019). A Prospective Trial of Withdrawal and Reinstitution of Ursodeoxycholic Acid in Pediatric Primary Sclerosing Cholangitis. Hepatology Communications. 3(11). 1482–1495. 16 indexed citations
5.
Murray, Karen F., William F. Balistreri, Sanjay Bansal, et al.. (2018). Safety and Efficacy of Ledipasvir–Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6‐11. Hepatology. 68(6). 2158–2166. 58 indexed citations
6.
Wirth, Stefan, Philip Rosenthal, Regino P. González‐Peralta, et al.. (2017). Sofosbuvir and ribavirin in adolescents 12‐17 years old with hepatitis C virus genotype 2 or 3 infection. Hepatology. 66(4). 1102–1110. 71 indexed citations
7.
Balistreri, William F., Karen F. Murray, Philip Rosenthal, et al.. (2016). The safety and effectiveness of ledipasvir−sofosbuvir in adolescents 12‐17 years old with hepatitis C virus genotype 1 infection. Hepatology. 66(2). 371–378. 123 indexed citations
8.
Reiff, Andreas, Kenneth I. Weinberg, Timothy J. Triche, et al.. (2013). T lymphocyte abnormalities in juvenile systemic sclerosis patients. Clinical Immunology. 149(1). 146–155. 14 indexed citations
9.
Lin, Chuan‐Hao, et al.. (2006). A Prospective Study Comparing Oral Sodium Phosphate Solution to a Bowel Cleansing Preparation with Nutrition Food Package in Children. Journal of Pediatric Gastroenterology and Nutrition. 42(2). 174–177. 27 indexed citations
10.
Lin, Chuan‐Hao, Ye-Shih Ho, Raymond G. Schipper, et al.. (2002). Expression of intestinal ornithine decarboxylase during postnatal development in neonatal rats. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1589(3). 298–304. 4 indexed citations
11.
Lin, Chuan‐Hao, et al.. (2001). Arginine Deficiency‐Induced Hyperammonemia in a Home Total Parenteral Nutrition‐Dependent Patient: A Case Report. Journal of Parenteral and Enteral Nutrition. 25(5). 286–288. 9 indexed citations
12.
Shashidhar, Harohalli, et al.. (2000). A Prospective Trial of Lansoprazole Triple Therapy for Pediatric Helicobacter pylori Infection. Journal of Pediatric Gastroenterology and Nutrition. 30(3). 276–282. 45 indexed citations
13.
Dahshan, Ahmed, Chuan‐Hao Lin, John Peters, Ronald Thomas, & Vasundhara Tolia. (1999). A Randomized, Prospective Study to Evaluate The Efficacy and Acceptance of Three Bowel Preparations for Colonoscopy in Children. The American Journal of Gastroenterology. 94(12). 3497–3501. 76 indexed citations
14.
Lin, Chuan‐Hao, et al.. (1997). Effect of Thyroxine on Pancreatic Digestive Enzymes and Ornithine Decarboxylase Gene Expression in Neonatal Rats. Journal of Pediatric Gastroenterology and Nutrition. 24(1). 18–24. 2 indexed citations
15.
Tolia, Vasundhara, Chuan‐Hao Lin, & Lawrence R. Kuhns. (1992). Gastric Emptying Using Three Different Formulas in Infants with Gastroesophageal Reflux. Journal of Pediatric Gastroenterology and Nutrition. 15(3). 297–301. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026